Pliant Therapeutics Inc Stock Ownership - Who owns Pliant Therapeutics?

Insider buying vs selling

Have Pliant Therapeutics Inc insiders been buying or selling?
Eric LefebvreChief Medical Officer2024-07-1012,319$11.56
Hans HullChief Business Officer2024-07-109,900$11.56
Bernard CouliePresident and CEO2024-07-1038,710$11.56
Keith Lamont CummingsChief Financial Officer2024-07-1010,911$11.56
Mike OuimetteGeneral Counsel Corp. Secy2024-07-107,656$11.56
Keith Lamont CummingsChief Financial Officer2024-05-0221,000$2.08
Bernard CouliePresident and CEO2024-01-1725,721$17.23
Keith Lamont CummingsChief Financial Officer2024-01-179,781$17.23
Hans HullChief Business Officer2024-01-179,786$17.23
Eric LefebvreChief Medical Officer2024-01-1710,295$17.23

1 of 2

PLRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PLRX insiders and whales buy or sell their stock.

PLRX Shareholders

What type of owners hold Pliant Therapeutics Inc stock?
Matthew G. Robinson26.64%16,069,177$212.60MInsider
Deep Track Capital LP9.53%5,750,000$76.07MInstitution
Blackrock Inc7.72%4,655,385$61.59MInstitution
Third Rock Ventures Iii LP7.45%4,495,238$59.47MInsider
Price T Rowe Associates Inc6.56%3,959,088$52.38MInstitution
Fmr LLC6.54%3,946,497$52.21MInstitution
First Light Asset Management LLC5.86%3,534,993$46.77MInstitution
Vanguard Group Inc5.77%3,478,355$46.02MInstitution
Laurion Capital Management LP5.76%3,474,744$45.97MInstitution
Redmile Group LLC5.13%3,097,220$40.98MInstitution

1 of 3

PLRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PLRX71.46%28.54%Net SellingNet Selling
OLMA73.90%26.10%Net BuyingNet Selling
PRME39.48%60.52%Net Buying
AUPH38.39%3.20%Net SellingNet Selling

Pliant Therapeutics Stock Ownership FAQ

Who owns Pliant Therapeutics?

Pliant Therapeutics (NASDAQ: PLRX) is owned by 108.06% institutional shareholders, 43.17% Pliant Therapeutics insiders, and 0.00% retail investors. Matthew G. Robinson is the largest individual Pliant Therapeutics shareholder, owning 16.07M shares representing 26.64% of the company. Matthew G. Robinson's Pliant Therapeutics shares are currently valued at $216.93M.

If you're new to stock investing, here's how to buy Pliant Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.